دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: سری: ISBN (شابک) : 9789819963386, 9789819963393 ناشر: سال نشر: 2024 تعداد صفحات: 359 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 14 مگابایت
در صورت تبدیل فایل کتاب Problem Based Learning Discussions in Onco-Anesthesia and Onco-Critical Care به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب بحث های یادگیری مبتنی بر مشکل در بیهوشی Onco و مراقبت بحرانی Onco-Critical نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
Foreword Contents About the Editors 1: Carcinoma Buccal Mucosa with Trismus Posted for Hemimandibulectomy and Free Flap Reconstruction 1.1 Introduction 1.2 Preoperative Assessment 1.2.1 Implications of RT CT 1.3 Preoperative Investigations 1.4 Preoperative Nutritional Optimisation 1.5 Intraoperative Management 1.5.1 The Shared Airway 1.6 Trismus 1.6.1 Airway Management in Trismus 1.7 Intraoperative Monitoring 1.8 Position of the Patient 1.9 Perioperative Management Including ERAS 1.10 Anaesthetic Considerations in Free Flap 1.10.1 Postoperative Flap Monitoring 1.11 Venous Thromboembolism Prophylaxis 1.12 Tracheostomy 1.13 Extubation 1.14 Criteria for ICU Admission in the Postoperative Perio 1.15 Analgesia Management References 2: Anaesthesia and Perioperative Concerns in Total Laryngectomy 2.1 Case Vignette 2.1.1 Define Total Laryngectomy? Contrast It with Other Partial Surgical Modalities 2.1.2 What Are the Quality of Life Affecting Concerns in a Patient Planned for ‘Total Laryngectomy’? 2.1.3 What Is the Incidence of Laryngeal Cancer in India and Worldwide? What Are the Main Risk Factors Associated with This Malignancy? 2.1.4 Describe the TNM Staging for Ca Larynx 2.1.5 How Do You Evaluate and Prehabilitate These Patients? 2.1.6 What Are the Toxicities Associated with Chemotherapeutic Agents Used in Ca Larynx? 2.1.7 What Can Be the Airway-Related Concerns in a Patient of Ca Larynx Posted for Total Laryngectomy? [5–7] 2.1.8 Specific Intraoperative Concerns? 2.1.9 Role of Enhanced Recovery After Surgery (ERAS) Protocols in Laryngectomy Cases? 2.1.10 Main Postoperative Concerns After Total Laryngectomy? 2.1.11 What Are the Available Options for Postoperative Voice Rehabilitation After Laryngectomy and a Permanent Tracheostome? List Out Complications of Such Voice Prosthetic Devices 2.2 Complications of Speech Valves 2.2.1 How Do You Manage a Post-laryngectomy Patient Posted for Other Surgical Procedures? 2.2.2 What Are the Complications of Laryngectomy? References 3: Carcinoma Trachea for Tracheal Resection and Anastomosis 3.1 Case 3.2 Preoperative Evaluation 3.2.1 Clinical Evaluation 3.3 Investigations 3.4 Surgical Considerations 3.5 Intraoperative 3.6 Extubation 3.7 Postoperative References 4: Anterior Mediastinal Mass for Mediastinoscopy and Proceed 4.1 Case Scenario 4.2 Introduction 4.3 Describe Anatomy of Mediastinum? 4.4 What is Differential Diagnosis of a Mediastinal Mass? 4.5 How do Patients with Mediastinal Mass Present Clinically? 4.6 Enumerate the Signs and Symptoms of Mediastanal Compression? 4.6.1 Tarcheobrpnchial Compresison 4.6.2 Vascular Compression 4.7 Enumerate Major Anesthetic Concernds in this Patient? 4.7.1 Preoperative Evaluation and Investigations 4.7.2 Discuss Anesthetic Management in this Patient 4.7.2.1 Induction and Intubation 4.7.2.2 Ventilation 4.8 Enumerate Special Consoderations for Mediastinoscopy 4.9 Enumerate Complictaions in the Postoperative Period 4.9.1 Respiratory Collapse 4.9.2 Cardiovascular Collapse 4.9.3 Emergence and Recovery 4.9.4 Postoperative Care References 5: Anesthetic Considerations for a Patient with Carcinoma Lung Scheduled for Lobectomy or Pneumonectomy 5.1 Case Scenario 5.2 Enumerate the Risk Factors, Major Types of Lung Malignancies, and Their Common Manifestations Along with Their Prognosis? 5.3 Enumerate the Advantages and Disadvantages of Different Surgical Options Available 5.4 What Different Evaluations Are Required for this Patient Apart from Routine Assessment? 5.5 Determining the Actual Contribution of the Segments to Current Overall Functioning of the Lungs 5.6 Other Risk Factors 5.7 What Aspects of Airway Evaluation Are Relevant to Management of These Patients? 5.8 What Are the Various Optimization Options Available for this Patient? 5.9 Why Is One Lung Ventilation (Lung Isolation) Required? Briefly Describe the Various Available Lung Isolation Techniques. Present the Intricacies of Choosing an Appropriate Lung Isolation Device for a Given Patient 5.10 Discuss the Anatomy of the Tracheobronchial Tree Relevant to One Lung Ventilation with Specific Emphasis on the Margin of Safety 5.11 Discuss the Relevance of Hypoxic Pulmonary Vasoconstriction (HPV) in These Patients. Detail the Influence of Anesthetic Agents on the HPV Response 5.12 What Preoperative Investigations and Premedication Are Required for this Patient? 5.13 Outline the Overall Flow of the Patient Scheduled for Thoracic Surgery 5.14 Discuss the Various Intraoperative Monitoring Options and Preparations Required During the Management of this Patient? 5.15 Describe the Technique of Left-Sided Double Lumen Tube Insertion and the Methods to Confirm Its Ideal Location 5.16 Confirmation of Ideal Positioning of the DLT 5.17 Describe the Technique of Insertion and Confirmation of Ideal Location of Bronchial Blockers 5.18 Discuss the Anesthetic Drug Choices for Induction and Maintenance of Anesthesia 5.19 Enumerate the Main Precautions to be Taken While Positioning the Patient in Lateral Decubitus Position 5.20 Discuss the Alterations in Ventilation and Perfusion Related to Lateral Decubitus Position, When Thorax Is Intact and When Open, with Patient Spontaneously Breathing and Paralyzed 5.21 Enumerate the Various Options for Intraoperative and Postoperative Analgesia 5.22 Discuss the Ventilatory Strategy for the Management of OLV 5.23 Detail Your Plan for Intraoperative Hypoxemia Management 5.24 Discuss the Essential Principles in Fluid Management in These Patients 5.25 Enumerate the High-Risk Factors for the Development of Post-procedure Acute Lung Injury 5.26 Outline the Salient Points for On Table Extubation of Patients Following Various Types of Lung Resection Surgery 5.26.1 Enumerate the Essential Principles for Postoperative Care of These Patients 5.26.2 Briefly Discuss the Immediate Life-Threatening Postoperative Problems and Discuss the Troubleshooting for the Same 5.26.3 Briefly Discuss the Differences Between Open Thoracotomy, VATS, and NIVATS with Respect to Anesthetic Techniques and Concerns 5.26.4 Discuss the Principles of Enhanced Recovery After Thoracic Surgery 5.27 What Are the Specific Considerations for the Patient with Post-pneumonectomy Status If Scheduled to Undergo (a) Another Lung Resection Surgery in the Future (b) to Undergo Incidental Surgery in the Future References 6: Malignant Melanoma Foot for Isolated Limb Perfusion 6.1 Case 6.2 What Is Malignant Melanoma (MM) and What Is the Incidence of the Disease? 6.3 What Are the Risk Factors for Malignant Melanoma? 6.4 How Is the Diagnosis of Malignant Melanoma Done? 6.5 What Is the TNM Staging of Malignant Melanoma? 6.6 What Are the Treatment Strategies Available for Malignant Melanoma? 6.7 What Are the Indications for HILP for Treatment of MM? 6.8 Briefly Describe the HILP in Brief 6.9 How Is HILP Different from Cardiopulmonary Bypass and What Precautions Are to Be Taken? 6.10 What Are the Special Anesthesia Preparations Required During the Preoperative Period? 6.11 Describe the Intraoperative Anesthesia Management 6.12 Describe the Operative and Perfusion Technique 6.13 What Are the Intraoperative Blood Testing Strategies? 6.14 What Is the Dose of Melphalan to Be Given Intraarterially During the Procedure? 6.15 What Are the Possible Side Effects Because of Usage of Melphalan? 6.16 Should Regional Anesthesia in the Form of Central Neuraxial Block Be Used During the Intraoperative Phase? 6.17 Why Core Body Temperature Monitoring Is Essential During the Surgery? 6.18 What Is the Importance of Close Monitoring of Limb Venous Pressure? 6.19 Which Are the Different Leak Assessment Techniques and What Are the Qualities of a Good Leak Assessment Test? 6.20 Mention the Other Drugs Which Can Be Used Apart from Melphalan? 6.21 What Are the Important Considerations in the Postoperative Phase? 6.22 Which Groups of Patients Are Considered High Risk and Not Eligible for the Procedure? 6.23 What Are the Other Oncological Cases Where the Use of Isolated Hyperthermia Perfusions Is Being Considered Apart from Malignant Melanoma? 6.24 What Are the Differences between HILP and ILI (Isolated Limb Infusion)? 6.25 What Are the Postoperative Complications of HILP and ILP? 6.26 Who all Must Be the Part of Multidisciplinary Team Management in a Case of HILP? References 7: Anesthetic Considerations for a Patient with Carcinoma Esophagus Scheduled for Ivor-Lewis Esophagectomy 7.1 Case Scenario 7.2 Introduction: Overview of Esophageal Carcinoma 7.2.1 Classify the Esophageal Neoplasms Based on Their Histological Characteristics 7.2.2 Is There Any Difference in the Histological Types of Ca Esophagus Between Developing and Developed Countries? How Does It Differ Between Upper and Lower Esophagus? 7.2.3 What Are the Risk Factors for Developing Ca Esophagus? 7.2.4 What Are the Common Presenting Symptoms of Carcinoma Esophagus? 7.2.5 What Are the Most Common Sites of Metastases in the Ca Esophagus? What Is the Median Survival/5-Year Survival Rate for Carcinoma Esophagus? 7.2.6 Describe the Eighth AJCC Staging of Carcinoma Esophagus and Their Clinical Implications? 7.2.7 What Are the Staging Investigations for Carcinoma Esophagus? 7.2.8 What Are the Treatment Options Available for Carcinoma Esophagus? 7.3 Preoperative Evaluation and Management 7.3.1 How Do You Evaluate These Patients in the PAC Clinic? 7.3.2 What Are the Systemic Toxicities of Preoperative Chemotherapies in a Patient with Carcinoma Esophagus? 7.3.3 What Are the Toxicities of Thoracic Radiation in Carcinoma Esophagus? 7.3.4 What Is the Ideal Time to Schedule a Patient for Surgery Who Has Received Neoadjuvant Therapies? 7.3.5 What Are the Preoperative Investigations Needed for This Patient? 7.3.6 What Are the Preoperative Procedure-Specific Risk Stratification Tools for Patients Posted for Esophagectomy? 7.3.7 How Will You Optimize the Patient with Carcinoma Esophagus Before Surgery? 7.3.8 What Will Be Your Preoperative Fasting Guidelines and Advice for Bowel Preparation for This Patient? 7.4 Intraoperative Management 7.4.1 Discuss the Premedication, Monitoring, and Anesthesia Plan for These Patients 7.4.2 Enumerate the Different Surgical Techniques Available and Discuss the Pros and Cons for Individual Techniques 7.4.3 Discuss the Concerns Associated with Surgical Techniques Contributing to Early Recovery in Esophagectomy Patients? 7.4.4 What Are the Concerns during Anesthesia Induction and Maintenance in These Surgeries? 7.4.5 How Do You Manage the Airway in these Patients and Discuss Their Pros and Cons? 7.4.6 Discuss the Intraoperative Ventilatory Strategies in These Patients 7.4.7 Outline the Management of Intraoperative Hypoxia During One-Lung Ventilation 7.4.8 Discuss the Intraoperative Fluid and Blood Products Management Strategies 7.4.9 What Will Be Your Extubation Strategy and Place for Postoperative Care? 7.5 Postoperative Management 7.5.1 Describe the Pain Management in Esophagectomy Patients 7.5.2 How Will You Manage the Drains, Tubes, Catheters, Feeding, and Thromboprophylaxis in the Postoperative Period? 7.5.3 What Are the Postoperative Complications That You Can Expect in Esophagectomy Patients? 7.5.3.1 Early Complications 7.5.3.2 Late Complications 7.5.4 How Do You Manage Postoperative Atrial Fibrillation Following Esophagectomy 7.5.4.1 Prevention of Arrhythmia 7.5.4.2 Treatment of Arrhythmia 7.5.5 Enumerate the Principles of ERAS in Esophagectomy References 8: Chondrosarcoma Pelvis for Internal Hemipelvectomy 8.1 Case Scenario 8.2 Pain Relief: Intraoperative 8.3 Component Therapy 8.3.1 Red Blood Cells 8.3.2 Fresh Frozen Plasma (FFP) 8.4 Techniques to Reduce Blood Loss 8.4.1 Anesthetic Strategies to Reduce Blood Loss 8.4.1.1 Permissive Hypotension Central Neuraxial Block 8.4.1.2 Patient Positioning 8.4.1.3 Avoidance of Hypothermia 8.4.1.4 Ventilation Strategies 8.4.2 Other Strategies to Reduce Blood Loss 8.4.2.1 Role of Antifibrinolytics 8.4.2.2 Diathermy 8.4.2.3 Topical Agents References 9: Periampullary Carcinoma for Whipple’s Procedure 9.1 Case 9.2 Pathophysiological Changes in the Gastrointestinal Tract 9.3 Renal System 9.4 Hepatic System 9.5 Cardiovascular Effects 9.6 Optimization of Pulmonary Function 9.7 Correction of Dehydration and Malnutrition 9.8 Correcting Coagulation Profile 9.9 Anti-Thrombotic Prophylaxis 9.10 Premedication 9.11 Induction Agents/Intravenous Anaesthetics 9.12 Inhalation Anaesthetics 9.13 Neuromuscular Blocking Drugs 9.14 Analgesics 9.14.1 Opioids 9.14.2 Acetaminophen 9.14.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 9.15 Intraoperative Fluid Management References 10: Anaesthetic Considerations in Patients with Carcinoma Prostate for Robot-Assisted Laparoscopic Radical Prostatectomy 10.1 Case Vignette 10.2 What Are the Risk Factors and Clinical Features of Ca Prostate? 10.3 Briefly Describe the Da Vinci System 10.4 What Are the Goals in Robotic Surgeries? What Are the Measures to Reduce the Complications? 10.5 What Is Docking of the Robot? 10.6 Describe the Preoperative Assessment Patients Posted for Robotic Prostatectomy 10.6.1 Preoperative Assessment 10.6.2 Ergonomics 10.7 Describe the Intraoperative Management of a Patient Posted for Robotic Prostatectomy 10.7.1 Intraoperative Management 10.7.2 Airway Management 10.7.3 Patient Positioning 10.7.4 Pulmonary Considerations 10.7.5 Haemodynamic Considerations 10.7.6 Monitoring 10.7.7 Intraoperative Fluid Therapy 10.8 What Are the Postoperative Issues and How Will You Manage Them? 10.8.1 Airway Management 10.8.2 Pain Management 10.8.3 Deep Venous Thrombosis(DVT) Prophylaxis 10.9 Describe the Enhanced Recovery After Surgery ERAS Protocols for Robotic Radical Prostatectomy 10.10 Summary References 11: Carcinoma Urinary Bladder for Cystectomy and Ileal Conduit 11.1 What Are Different Available Treatment Options for Carcinoma Urinary Bladder? 11.2 What Is Neoadjuvant Chemotherapy? What Are the Side Effects of Cisplatin? 11.3 Describe Radical Cystectomy. How Do You Define Ileal Conduit? What Are Alternative Diversion Procedures Available? 11.4 Preoperative Evaluation and Optimization 11.4.1 How Would You Evaluate the Patient Preoperatively? What Preoperative Work-Up Is Required? 11.4.2 What Are the Common Types of Bladder Cancer? Describe the Risk Factors Associated with Bladder Cancer? 11.4.2.1 Thromboprophylaxis 11.4.2.2 Preoperative Fasting 11.4.2.3 Antimicrobial Prophylaxis 11.4.2.4 Prevention of PONV 11.5 Intraoperative Period 11.5.1 Discuss Monitoring and Anesthesia Plan for these Patients. What Are Intraoperative Considerations? 11.5.2 How to Prevent Intraoperative Hypothermia in These Extensive Surgeries? 11.5.3 How to Monitor Urine Output in Genitourological Surgeries? 11.5.4 Enumerate the Different Anesthetic Plans Available and Discuss Their Pros and Cons 11.5.5 Discuss the Fluid Management in these Patients 11.5.6 Discuss all Available Options for Perioperative Analgesia 11.6 Postoperative Period 11.6.1 Enumerate the Postoperative Complications that May Arise in Immediate Postoperative Period in these Patients. Discuss the Principles of Enhanced Recovery after Genitourinary Surgery 11.6.2 Components of ERAS Protocol in Radical Cystectomy 11.6.3 Describe the Risk Factors Associated with Morbidity and Mortality Following Radical Cystectomy References 12: Renal Cell Carcinoma for Laparoscopic Nephrectomy 12.1 Case References 13: Carcinoma Cervix for Pelvic Exenteration 13.1 Case 13.2 What Is Pelvic Exenteration? 13.3 What Are the Indications and Contraindications for PE? 13.4 How Will you Evaluate and Prepare for this Patient Prior to Surgery? 13.5 What Are the Anaesthetic Considerations for PE? 13.6 How Will you Ensure Smooth Coordination of Care? 13.7 What Is the Role of Mechanical and Pharmacological Thromboprophylaxis? 13.8 What Is the Correct Positioning of the Patient During PE? 13.9 What Are Your Strategies for Intraoperative Fluid Management? 13.10 How Will you Prevent Intraoperative Hypothermia? 13.11 How Do you Anticipate Possible Massive Haemorrhage? 13.12 What Are your Strategies for Pain Management? 13.13 How Would you Manage Stress Responses and What Are Your Strategies for Postoperative Care? 13.14 What Are the Postoperative Complications? References 14: Anaesthetic Management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy 14.1 Case 14.2 HIPEC 14.2.1 What Are the Indications/Contraindications for HIPEC? 14.2.2 What Are the Criteria for Patient Selection for These Procedures 14.2.3 What Are the Disease Scoring Systems Used for Patient Selection/Prognostication in HIPEC? 14.2.4 What Is the Rationale Behind HIPEC? 14.2.5 What Are the Methods/Techniques for Intraperitoneal Administration of Hyperthermic Chemotherapy? 14.2.6 What Are the Advantages and Disadvantages of Open and Closed Technique? 14.2.7 What Is the Choice of Chemotherapeutic Drug and Drug Dosaging for HIPEC? What Are its Implications on Perioperative Period? 14.2.8 What Are Adverse Effects of Specific Chemotherapeutic Agents Used for HIPEC? 14.2.9 What Different Evaluations/Preoperative Risk Assessment Are Required for This Patient Apart from Routine Assessment? 14.2.10 What Is the Role of Prehabilitation in This Patient? 14.2.11 What Are the Anaesthetic Considerations for CRS + HIPEC? 14.2.12 Enumerate the Physiological Alterations That May Occur During HIPEC, and Its Anaesthetic Implications 14.2.13 What Risks Are Present During Induction of This Patient? How Are They Planned for? 14.2.14 What Precautions/Premedications Would You Take Before Incision? 14.2.15 Discuss the Various Intraoperative Monitoring Options 14.2.16 Describe the Anaesthetic Drugs of Choice for This Procedure 14.2.17 Discuss the Essential Principles for Fluid Management and Blood Product Transfusion in These Patients 14.2.18 What Will Be Your Approach Towards Transfusion of Blood Products During This Surgery? 14.2.19 Why Is It Important to Monitor Coagulation Status of These Patients in the Perioperative Period? 14.2.20 What Is the Role of Monitoring Urine Output During This Surgery? 14.2.21 Why Do We Need to Cautiously Monitor for Electrolyte Imbalance? 14.2.22 Why Is Glycaemic Control Difficult in These Patients? 14.2.23 Enumerate the Various Options for Intraoperative and Postoperative Analgesia 14.2.24 Describe the Implications in Intraoperative Temperature Control 14.2.25 Enumerate the Physiological Alterations and Its Implications in the Postoperative Period 14.2.26 What Are the Occupational Safety Concerns for Professionals Involved in the Perioperative Care of This Patient? References 15: Hepatic Metastases for Right Hepatectomy 15.1 General Considerations 15.2 Preoperative Management of Liver Resection 15.3 Intraoperative Management of Liver Resection 15.4 Postoperative Management References 16: Ca Rectum for Laparoscopic Abdomino-Perineal Resection 16.1 Case Scenario References 17: CA Osteosarcoma for Below-Knee Amputation 17.1 Introduction 17.2 Psychological Evaluation 17.3 Perioperative Antibiotics 17.4 Premedication 17.5 Positioning References 18: Anaesthesia for Bone Marrow Aspiration and Biopsy 18.1 Case 18.2 What Is BMA and BMB? 18.3 What Are the Indications of Bone Marrow Aspiration (BMA) [1]? 18.4 What Are the Indications of Bone Marrow Biopsy (BMB)? 18.5 What Are the Contraindications for BMA and BMB? 18.6 How It Is Performed? 18.7 What Are the Complications? 18.8 Need for Anaesthesia during BMA and BMB 18.9 How Will You Do the Pre-anesthetic Evaluation? 18.10 Care of Immunocompromised Child 18.10.1 Strict Aseptic Measures 18.10.2 Care of Central Venous Lines 18.11 What Are the Goals of Anaesthesia? 18.12 What Anaesthesia Is Used for BMA and BMB? 18.12.1 Adults 18.13 Post Procedure Care References 19: Paediatric Case of Medulloblastoma for Whole Brain Radiotherapy 19.1 Case Vignette References 20: Anaesthetic Considerations for a Patient with Carcinoma Prostate Planned for Brachytherapy 20.1 Case Vignette 20.2 Introduction 20.3 Pre-procedural Concerns: Patient-Related Factors 20.4 Intra-procedural Concerns: Procedure-Related, Positioning, Anaesthetic Options 20.5 Post-procedural Concerns: Analgesia, Resuming Normal Activities and Discharge References 21: Wilms Tumour 21.1 Case Scenario References 22: Paediatric Case of Mediastinal Mass for USG-/CT-Guided Biopsy 22.1 Case Scenario 22.2 Give an Overview of Mediastinal Masses 22.3 What Are the Clinical Presentation of Children with Mediastinal Mass? 22.4 What Are the Predictors of Acute Perioperative Cardiorespiratory Complications in Patients with Anterior Mediastinal Mass? (Table 22.1) 22.5 How Do You Risk Stratify These Patients? 22.6 Describe the Pre-operative Management of Mediastinal Mass 22.7 What Are the Mechanisms by Which General Anaesthesia Causes Cardiorespiratory Collapse in a Patient with Anterior Mediastinal Mass? 22.8 What Is the Post Procedural Management of These Cases? 22.9 What Are the Complications of This Procedure? References 23: Unresectable Carcinoma Gall Bladder for Percutaneous Transhepatic Biliary Drainage 23.1 Case Study 23.2 What Is the Worldwide Incidence of Carcinoma Gall Bladder [1]? 23.3 Discuss Epidemiology of CAGB in India 23.4 Describe in Brief the Pathophysiology and Risk Factors for CAGB [3, 7, 8] 23.4.1 Anatomical Factors 23.4.2 Geographic or Environmental Factors 23.4.3 Dietary Factors 23.4.4 Others 23.5 Discuss Clinical Presentation and Staging of CAGB [3, 8] 23.6 What Are Presenting Symptoms of CAGB [4, 14]? 23.7 What Are the Diagnostic Modalities for Diagnosis of CAGB [8, 16, 17]? 23.8 Common Symptoms Associated with Advanced CAGB [18, 19] 23.9 What Are Current Treatment Options Available for CAGB [20] 23.9.1 Adjuvant Treatments 23.10 What Are Modalities of Palliation for Obstructive Jaundice in Advanced or Unresectable CAGB [19] 23.11 What Is the Procedure of PTBD and Its Benefits and Uses. Describe the Procedure of PTBD [29] 23.12 What Are the Types of PTBD? 23.13 What Are the Available Approaches for PTBD? 23.14 What Is Percutaneous SEMS? 23.15 What Are the Possible Complications During PTBD? 23.16 What Are Other Alternatives to Achieve Biliary Drainage Apart from PTBD [18, 32, 33]? 23.17 What Is the Evidence for Utility of EUS-BD [34]? References 24: Case of Liver Metastasis for RFA 24.1 Case History 24.2 Introduction 24.3 What Are the Different Modalities of Treatment for Liver Metastasis? 24.4 What Is RFA? 24.5 What Are the Advantages of RFA? 24.6 How RFA Performed? 24.7 Indication of Liver RFA? 24.8 Limitations of RFA 24.9 What Are the Goals of Anaesthesia in a Patient Posted for Liver RFA? 24.10 What Are the Anaesthesia Concerns in RFA? 24.11 What Are Different Anaesthesia Techniques Used for Liver RFA? 24.12 The Minimum Monitoring Required for RFA? 24.13 Minimum Anaesthesia Equipment for PRFA Procedures 24.14 Enumerate the Complications of RFA 24.14.1 Prognosis 24.15 Perioperative Antibiotic Prophylaxis References 25: Tumour Lysis Syndrome 25.1 Case History 25.2 Physical Examination 25.3 Renoprotective Measures 25.3.1 Rapid Expansion of Intravascular Volume 25.3.2 Diuresis 25.4 Correction of Electrolyte Imbalance 25.4.1 Hypocalcaemia 25.4.2 Hyperkalaemia 25.4.3 Hyperphosphataemia 25.4.4 Hyperuricaemia 25.4.4.1 Allopurinol 25.4.4.2 Recombinant Urate Oxidase (Rasburicase) [5, 18–20] 25.4.4.3 Febuxostat 25.4.4.4 Sodium Bicarbonate (Alkalisation of Urine) [1, 14–18] 25.4.4.5 Haemodialysis References 26: Carcinoma Base of the Tongue with Acute Stridor 26.1 Case 26.2 Cancer of the Base of the Tongue 26.3 Anaesthesia Considerations 26.3.1 Pre-op Considerations 26.3.2 Awake Fibreoptic Technique 26.3.3 Inhalational Induction 26.3.4 Anaesthesia for a Patient with Acute Stridor 26.3.5 History 26.3.5.1 Examination References 27: A Case of Carcinoma Colon with Febrile Neutropenia 27.1 Aetiology and Risk Factors 27.2 Screening 27.3 Prevention 27.3.1 Pathology 27.4 Signs and Symptoms 27.5 Diagnostic Workup 27.6 Prognostic and Risk Factors 27.6.1 Medical Therapeutic Modalities 27.7 The Febrile, Neutropenic Patient 27.8 Pathophysiology [1–5] 27.9 Radiologic Studies 27.10 Treatment [2, 4, 5, 8–12] References 28: CA Breast with Spinal Cord Compression 28.1 Case Scenario 28.2 What Is the Incidence and Common Symptoms of Presentation of Metastatic Spinal Cord Compression (MSCC) from Various Carcinoma? 28.3 How Do Patients with MSCC Present? What Are the Key Clinical Findings That Help Us to Diagnose? 28.4 Explain the Different Theories of Pathophysiology Behind the MSCC 28.5 What Are the Investigations Required to Diagnose the MSCC? 28.6 What Should Be Your Initial Plan of Management? 28.7 How Can the Patient with Suspected MSCC Be Positioned for Care? 28.8 What Is the Role and Dose of Glucocorticoids? 28.9 Which Modalities Are Available for Pain Relief? 28.10 When Will the Patient Be Considered a Candidate for Surgery? 28.11 Are There Any Objective Criteria to Decide Between Surgery and Radiotherapy? 28.12 When Is the Radiation Therapy Indicated? 28.13 What Is the Role of Bisphosphonates? 28.14 What Is the Role of Rehabilitation in These Patients? 28.15 What Thromboprophylaxis Measures Should Be Taken for These Patients? 28.16 How Will You Prevent Pressure Ulcers? 28.17 How to Manage Bladder and Bowel Continence? 28.18 How Will You Ensure Adequate Circulatory and Respiratory Functioning? 28.19 What Will Be Your Rehabilitation Plan After the Patient Is Discharged? 28.20 How to Evaluate Quality of Life (QoL) in These Patients? References 29: Ca Endometrium with Long-Standing Diabetes Mellitus for Radical Hysterectomy 29.1 Case Scenario References 30: Anaesthetic Considerations for a Child with Retinoblastoma for Orbital Enucleation 30.1 Case History 30.2 Introduction 30.2.1 Primary Concerns 30.2.2 Preoperative Evaluation 30.2.3 Anaesthesia Management 30.2.3.1 Premedication 30.2.3.2 Induction of Anaesthesia 30.2.3.3 Airway Management 30.2.3.4 Maintenance of Anaesthesia 30.2.3.5 Oculocardiac Reflex (OCR) 30.2.3.6 Intraoperative Analgesia Postoperative Care References 31: Anaesthesia for Central Airway Obstruction 31.1 What Are the Causes of Central Airway Obstruction (CAO)? 31.2 Describe the Airway Stents 31.3 What Are the Complications of Airway Stenting? 31.4 What Are the Anaesthetic Considerations in this Procedure? 31.5 What Are the Local and Systemic Effects of Malignancy that Can Have Anaesthetic Implications? 31.5.1 Systemic Effects [19] 31.5.2 Local Effects [19] 31.6 What Pre-Procedural Preparation Can Be Done Before the Bronchoscopy? 31.7 What Are the Anaesthetic Considerations for Rigid Bronchoscopy? 31.8 What Are the Anaesthetic Techniques that Can Be Used in These Procedures? 31.8.1 Induction of Anaesthesia 31.8.2 Maintenance of Anaesthesia 31.9 What Are the Anaesthetic Considerations in Patients with an Airway Stent Posted for Unrelated Procedures? 31.10 What Are the Modes of Ventilation that Can Be Used During Rigid Bronchoscope Procedures? References 32: Anaesthetic Management of Pheochromocytoma 32.1 Case History 32.2 What Is Pheochromocytoma? 32.3 Case 32.4 What Are the Signs and Symptoms of Pheochromocytoma? [1, 2] 32.5 What Is the Mechanism of Orthostatic Hypotension? 32.6 What Is Catecholamine-Induced Cardiomyopathy? 32.7 How Will You Confirm your Diagnosis? 32.7.1 Biochemical Tests 32.7.2 Imaging Studies 32.8 How Will You Evaluate and Optimise this Patient for the Surgery? 32.8.1 Evaluation 32.8.2 Optimisation 32.9 Why Is it Necessary to Initiate Alpha-Blockade in These Patients? 32.10 Why Should Alpha-Blockade Be Initiated before Beta-Blockade? 32.11 What Are the Drugs Used to Control the Blood Pressure? (Table 32.5) 32.12 How Will the Surgical Technique Affect your Anaesthesia Choices? 32.12.1 What Are your Anaesthetic Considerations? 32.13 What Is the Aetiology of Intraoperative Hypotension? 32.14 How Will you Monitor the Patient Intraoperatively? 32.15 Are Arterial Pulse Contour Analysis Devices Useful in Pheochromocytoma Surgery? 32.16 What Are the Postoperative Complications? 32.17 How Will you Manage a Pheochromocytoma Which has Been Incidentally Detected During Routine Surgery? 32.18 How Will You Manage a Patient Who Is Diagnosed with a Pheochromocytoma During Pregnancy? References 33: A Case of Carcinoma Breast with Brain Metastasis for Gamma Knife Radiosurgery 33.1 Case History 33.2 What Are the Various Types of Breast Cancer? What Are the Risk Factors and Its Manifestations? 33.3 What Are the Common Sites and Symptoms of Metastasis in Patients of Breast Cancer? 33.4 What Are the Incidence, Prognosis, and Risk Factors for Brain Metastasis in Patients of Breast Cancer? 33.5 What Are the Treatment Options and Prognosis After Treatment for Brain Metastasis in Breast Cancer Patients? 33.6 What Is Stereotactic Radiosurgery? 33.7 Enumerate the Advantages of SRS 33.8 What Are the Indications and Contraindications for SRS in Breast Cancer Patients with Brain Metastasis? 33.9 How Is a Patient Evaluated and Prepared for Gamma Knife Radiosurgery? 33.10 What Is the Workflow of Treatment for the Patient Posted for Gamma Knife Radiosurgery? 33.11 What Are the Local Anesthetic Drugs that Can Be Used for Placement of the Stereotactic Frame? 33.12 How Is the Patient Monitored and Positioned During the Procedure? 33.13 What Are the Anesthetic Considerations before Taking a Patient for Gamma Knife Surgery? 33.14 How Is Monitored Anesthesia Care (MAC) Provided for Gamma Knife Surgery? 33.14.1 Procedure 33.14.2 Discharge 33.14.3 Follow-Up 33.15 What Are the Indications of General Anesthesia for Gamma Knife Radiosurgery and How Is It Accomplished? 33.15.1 Induction 33.15.2 Maintenance 33.15.3 Extubation and Recovery 33.16 What Are the Complications Associated with Gamma Knife Treatment? References 34: Case of Carcinoma Urinary Bladder for Proton Radiation Therapy 34.1 How Is the Cancer Burden in the World? 34.2 What Is the Incidence of Urinary Bladder Cancer? 34.3 Who Are more Affected with Urinary Bladder Cancer? 34.4 What Are the Risk Factors of Bladder Cancer? 34.5 How Does Bladder Cancer Patients Present? 34.6 What Are the Common Sites of Metastasis of Bladder Cancer? 34.7 What Are Different Types of Bladder Cancer and their Prognosis? 34.8 What Is the Prognosis of Different Types of Bladder Cancer? 34.9 What Are the Various Management Options for Bladder Cancer? 34.10 What Is Proton Radiation Therapy (PBT)? 34.11 What Are the Advantages of Proton Radiation Therapy? 34.12 What Are the Side Effects of PBT? 34.13 What Are the Anesthetic Considerations in Patients Posted for Proton Radiation Therapy? 34.14 What Challenges an Anesthesiologist Face in an Outside Operating Room Environment? 34.15 What Are the Patient-Related Concerns? 34.16 What Positional Care Should Be Taken by Anesthesiologist During Proton Beam Radiotherapy in Other Tumors? 34.17 What Are the Implications of Tight-Fitting Immobilization Face Mask During Proton Therapy? 34.18 Discuss the Pain and Palliative Care Management Strategies for Urinary Bladder Cancer Patient 34.19 What Are the Domains Where Bladder Cancer Patients Need Care? References 35: Case of Ca Lung for EBUS and TBNA 35.1 Discuss the Basic Principles of Bronchoscopy 35.2 What Are the Equipment and Techniques Utilized for EBUS 35.2.1 Basic Description of EBUS 35.3 What Are Physiological Effects of Bronchoscopy? 35.4 What Are the Indications of EBUS? 35.5 Discuss the Preoperative Evaluation and Optimization of Patients Posted for EBUS 35.6 Discuss the Preparation and Safety Required for the Conduct of EBUS Procedure 35.7 What Is the Anesthesia Technique Practiced for the Conduct of EBUS? 35.8 What All Modalities Are Available for Maintenance of Anesthesia? 35.9 Discuss the Monitoring Techniques for the Procedure 35.10 What All Oxygenation and Ventilation Strategies Can Be Utilized for EBUS? 35.11 What Are the Complications of EBUS Procedure? 35.12 What Are the Contraindications of EBUS? 35.13 What Are the Limitations of EBUS? 35.14 Briefly Describe the Postoperative Care References 36: Anesthesia and Cancer Recurrence 36.1 Case Scenario 36.2 What Are the Common Survival Metrics Measured in Cancer Patients? 36.3 Briefly Summarize the Immunological Viewpoint of Cancer Recurrence 36.4 How Do the Commonly Used Anesthetic Agents Affect the Immune System? 36.5 Based on Available Evidence, How Are the Anesthetic Agents and Anesthetic Techniques Implicated in Cancer Recurrence? 36.6 Apart from Immunomodulation, How Does Perioperative Anesthesia Care Affect Long-term Oncological Outcomes? 36.7 Given the Equivocal Evidence for Anesthesia and Cancer Recurrence, What Should the Perioperative Plan of Action Be? 36.8 How Will you Approach the Patient Given in the Case Scenario? References